NEW PHARMACEUTICALS. HOW CAN INNOVATIVENESS?
Abstract
The article describes the basic approaches to evaluating innovativeness of pharmaceuticals, Russian and foreign experience is represented. The authors pay particular attention to the state involvement in the promotion of new products and create regulatory systems for quality control. The issues of creating a unified system of evaluation of pharmaceuticals innovativeness, which is associated with the need to develop a total innovativeness of pharmaceuticals «scale».
Key words: innovations, innovativeness, therapeutic innovativeness.
Key words: innovations, innovativeness, therapeutic innovativeness.
About the Authors
V.V. Omel'yanovskii
Research Centre of Clinical and Economical Expertise and Pharmacoeconomics of N.I. Pirogov Russian State University, Moscow
Russian Federation
Russian Federation
M.V. Sura
Research Centre of Clinical and Economical Expertise and Pharmacoeconomics of N.I. Pirogov Russian State University, Moscow
Russian Federation
Russian Federation
N.D. Sveshnikova
Research Centre of Clinical and Economical Expertise and Pharmacoeconomics of N.I. Pirogov Russian State University, Moscow
Russian Federation
Russian Federation
Review
For citations:
Omel'yanovskii V., Sura M., Sveshnikova N. NEW PHARMACEUTICALS. HOW CAN INNOVATIVENESS? Pediatric pharmacology. 2011;8(4):30-35.
Views:
592
Email this article 